Shared Care Agreements

Shared care agreements are developed when sophisticated or complex treatments that were initiated in secondary care are then to be prescribed by a GP. The shared care agreements are written by hospital specialist but approved for use by commissioners. The shared care agreement sets out the process that needs to be followed for the GP to take on prescribing responsibility; it details the responsibilities of the specialist, the GP and the patient to ensure that the medication can be prescribed safely.

A hospital consultant requesting a GP to prescribe a medicine for an individual named patient with a Wolverhampton formulary status of “shared care” should provide a copy of the appropriate shared care agreement. If this document is not provided, the GP should not consider prescribing the medication until the shared care document is received for inclusion in the patient record.

All shared care agreements have an expiry date that relates to when the clinical information contained within the document must be reviewed. Once signed the shared care agreement between the consultant, the GP and the patient has no end date while the patient continues to take the medicine. Prescribers are however advised to check the shared care section of the Medicines website for current monitoring details if the shared care agreement in the patient’s notes is past its review date.

Please note we are currently undergoing a review of all RWT shared care agreements. In the meantime please use those listed below.

ESCA Service Specific Additional Information
6 Mercaptopurine (Puri-Nethol®) Gastrointenstinal  
Apomorphine Neurology  
Atomoxetine (ADHD) RWT - Paediatrics  
Atomoxetine (ADHD) BCP - Child and Adolescent Mental Health Services (CAMHS)  
Azathioprine    
Bicalutamide    
Ciclosporin (Neoral®) Renal Hospital only from July 2017 (no new shared care patients)
Denosumab Rheumatology  
Dexamphetamine (ADHD) RWT - Paediatrics  
Dexamphetamine (ADHD) BCP - Child and Adolescent Mental Health Services (CAMHS)  
Donepezil Mental Health  
Dronedarone Cardiology  
Galantamine Mental Health  
Hydroxychloroquine Rheumatology  
Lanthanum Renal Hospital/specialist only from May 2018 (no new shared care patients)
Leflunomide    
Letrozole Oncology  
Lisdexamfetamine RWT - Paediatrics  
Lithium GP Monitoring Mental Health  
Lithium Hospital Monitoring Mental Health  
Melatonin BCP - Child and Adolescent Mental Health Services (CAMHS)  
Memantine Mental Health  
Methotrexate    
Methylphenidate (ADHD) Mental Health  
Methylphenidate (ADHD) RWT - Paediatrics  
Methylphenidate (ADHD) BCP - Child and Adolescent Mental Health Services (CAMHS)  
Mycophenolate mofetil (Cellcept®) Renal Hospital/specialist only from May 2018 (no new shared care patients)
Mycophenolate mofetil (Cellcept®) Respiratory Hospital/specialist only from May 2018 (no new shared care patients)
Mycophenolate mofeti (Cellcept®) Rheumatology Hospital/specialist only from May 2018 (no new shared care patients)
Mycophenolic acid (Myfortic®) Renal Hospital/specialist only from May 2018 (no new shared care patients)
Penicillamine GP Monitoring Rheumatology Hospital only from July 2017 (no new shared care patients)
Penicillamine Hospital Monitoring Rheumatology Hospital only from July 2017 (no new shared care patients)
Rivastigmine Mental Health  
Sevelamer Renal Hospital/specialist only from May 2018 (no new shared care patients)
Sirolimus Renal Hospital/specialist only from May 2018 (no new shared care patients)
Sodium aurothiomalate GP Monitoring Rheumatology Hospital only from July 2017 (no new shared care patients)
Sodium aurothiomalate Hospital Monitoring Rheumatology Hospital only from July 2017 (no new shared care patients)
Sulfasalazine    
Tacrolimus Renal Hospital/specialist only from May 2018 (no new shared care patients)